Medical Devices: Page 7
-
Glucotrack plans US trial of implantable glucose monitor this year
Glucotrack plans to file for an investigational device exemption in the second quarter, with hopes of starting a trial in the second half of 2026.
By Elise Reuter • March 27, 2026 -
Philips wins FDA clearance for imaging device developed with Edwards
The system uses AI to optimize the placement of Edwards’ mitral valve repair device.
By Nick Paul Taylor • March 27, 2026 -
Explore the Trendline➔
Courtesy of Intuitive Surgical
TrendlineRobotic surgery's innovation boom
Surgical robotics is one of the most exciting spaces in the medical device industry, with companies developing new systems and battling for market share.
By MedTech Dive staff -
Endologix to close production facility, lay off 31 people
The company acquired the facility in the PQ Bypass takeover it struck in the aftermath of its bankruptcy filing.
By Nick Paul Taylor • March 26, 2026 -
Retrieved from NASA's Moderate Resolution Imaging Spectroradiometer.
Manufacturers brace for price increases from Strait of Hormuz closure
Crude oil prices have surged 47% this month and polypropylene jumped 24%, affecting transportation and plastics costs.
By Nathan Owens • March 26, 2026 -
CMR Surgical robot builds momentum ahead of US rollout
CMR Surgical is formally introducing its Versius robot at a surgeons’ meeting this week in what CEO Massimiliano Colella described as a “watershed moment” for the company.
By Susan Kelly • March 26, 2026 -
Meet 8 medtech companies redefining surgical robotics
Executives at companies innovating new robotic surgery platforms shared their progress and challenges with MedTech Dive. Read our series of stories on the next generation of surgical robot developers.
By Susan Kelly • Updated June 22, 2026 -
Medtronic lowers earnings forecast after MiniMed IPO
The timing of the initial public offering and the clearance of a new insulin pump are expected to affect Medtronic’s results for its 2026 fiscal year.
By Elise Reuter • March 25, 2026 -
Medtronic’s OmniaSecure defibrillation lead earns expanded FDA indication
The OmniaSecure lead gained the first U.S. approval for placement in the heart’s left bundle branch area, to help activate the natural electrical system.
By Susan Kelly • March 25, 2026 -
Medtronic to distribute Merit Medical’s low back pain treatment
Merit’s basivertebral nerve ablation system is expected to round out Medtronic’s pain treatment options.
By Elise Reuter • March 24, 2026 -
GE HealthCare wins FDA nod for photon-counting CT technology
The 510(k) decision clears the company to challenge Siemens Healthineers for an emerging part of the CT imaging sector.
By Nick Paul Taylor • March 24, 2026 -
SS Innovations ramps up in telesurgery; XCath robot treats stroke remotely
SS Innovations’ robot won approvals to perform telesurgery in Indonesia and the Philippines, while the first remote robotic mechanical thrombectomy to treat stroke was performed with XCath’s system.
By Susan Kelly • March 24, 2026 -
FTC creates healthcare task force
The task force will share resources and coordinate enforcement across the Federal Trade Commission’s disparate bureaus to better address consumer protection and competition issues in healthcare, the FTC commissioner said.
By Rebecca Pifer Parduhn • March 23, 2026 -
Retrieved from Owen Mumford on March 19, 2026
Embecta to buy Owen Mumford for up to $201M
The planned purchase would allow Embecta to serve patients outside of diabetes care.
By Elise Reuter • March 19, 2026 -
JenaValve snags FDA approval in aortic regurgitation
The approval comes two months after Edwards Lifesciences scuttled plans to buy JenaValve for $945 million amid opposition from the Federal Trade Commission.
By Susan Kelly • March 18, 2026 -
MiniMed gets FDA nod for smaller insulin pump
MiniMed Flex is a smartphone-controlled insulin pump about half the size of MiniMed’s previous device. It’s the company’s first launch since separating from Medtronic in early March.
By Elise Reuter • March 18, 2026 -
PFA startup Field Medical appoints Mark Turco as CEO
Turco, an interventional cardiologist, has held roles including CEO of JC Medical and chief medical officer of Medtronic’s aortic and peripheral vascular business.
By Nick Paul Taylor • March 18, 2026 -
Baxter CFO Joel Grade steps down
Grade is leaving after a two-year stint defined by changes to Baxter’s business, including the sale of its kidney care unit.
By Nick Paul Taylor • March 18, 2026 -
Vicarious Surgical applies for Nasdaq listing
The robotics company reduced its 2026 cash burn forecast and said its development timeline remains on track, with a system design freeze expected by year-end.
By Susan Kelly • March 16, 2026 -
EPA proposes weakening ethylene oxide emission regulations
The proposal would relax standards for facilities that use ethylene oxide, a cancer-causing gas, to sterilize medical devices.
By Elise Reuter • March 16, 2026 -
Insulet reports 18 serious adverse events with recall of Omnipod 5 insulin pumps
The company is recalling certain lots of its insulin patch pumps after finding a small tear in the internal tubing may cause insulin to leak inside the pod.
By Elise Reuter • March 13, 2026 -
Advita Ortho receives warning letter related to shoulder system
Advita Ortho was formed after orthopedic implant maker Exactech sold its assets in bankruptcy.
By Elise Reuter • March 12, 2026 -
Insulet posts clinical data on fully closed-loop insulin delivery system
The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.
By Nick Paul Taylor • March 12, 2026 -
Medtronic elevates Sean Haag to president of ENT
Haag, who has worked at Medtronic for 20 years, will also serve on the leadership team for the neuroscience group.
By Susan Kelly • March 11, 2026 -
Coloplast names former J&J executive Gavin Wood as CEO
Wood spent 20 years at J&J, culminating in a spell as company group chairman for the medtech business in Europe, the Middle East and Africa.
By Nick Paul Taylor • March 11, 2026 -
Vitestro raises $70M to ready blood collection robot for US launch
The company is scaling up manufacturing and commercial activities as it prepares to enter the U.S. market via the Food and Drug Administration’s de novo pathway.
By Nick Paul Taylor • March 11, 2026